Open AccessChanges of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy
Author(s) -
Xinsheng Wang,
Haifeng Han,
Dawei Qi,
Uzair Khan,
Yonghao Hu,
Xiaomei Yao
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.137953
Subject(s) - hypoalbuminemia , medicine , chemotherapy , albumin , gastroenterology , lung cancer , serum albumin , toxicity , cancer
Hypoalbuminemia and systemic inflammatory response (SIR) parameters are a key role in the prognosis of cancer patients. We aim to investigate the changes of serum albumin level and SIR after chemotherapy, in patients with inoperable non-small cell lung cancer (NSCLC). The hypothesis is that improved serum albumin level may be beneficial to the SIR parameters and will reduce chemotherapy-induced toxicity.